Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study

INTRODUCTION: A still not well defined proportion of patients with multiple myeloma (MM) and eligible for autologous stem cell transplantation (AuSCT) fails to mobilize CD34+ peripheral blood stem cells (PBSC) at all or to collect an adequate number for a safe procedure or sufficient for multiple tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Musto, Pellegrino, Simeon, Vittorio, Grossi, Alberto, Gay, Francesca, Bringhen, Sara, Larocca, Alessandra, Guariglia, Roberto, Pietrantuono, Giuseppe, Villani, Oreste, D’Arena, Giovanni, Cuomo, Carmela, Musto, Clelia, Morabito, Fortunato, Petrucci, Maria Teresa, Offidani, Massimo, Zamagni, Elena, Tacchetti, Paola, Conticello, Concetta, Milone, Giuseppe, Palumbo, Antonio, Cavo, Michele, Boccadoro, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425876/
https://www.ncbi.nlm.nih.gov/pubmed/25889496
http://dx.doi.org/10.1186/s13287-015-0033-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4425876/
https://www.ncbi.nlm.nih.gov/pubmed/25889496
http://dx.doi.org/10.1186/s13287-015-0033-1

Ejemplares similares